Opinion
Video
Author(s):
Dr. Chapin and fellow expert oncologists discuss the latest data from the LIGHTHOUSE trial, evaluating 18F-rhPSMA-7.3 for staging patients with prostate cancer.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.